India's Serum Institute Re-launches H1N1 Flu Vaccine
This article was originally published in PharmAsia News
Executive Summary
The Serum Institute of India's NasoVac vaccine, developed to guard against the H1N1 flu, has been re-launched within a month of its expiration date